NESS ZIONA, Israel, Dec. 19, 2017 /PRNewswire/ — BiomX Ltd., a microbiome company developing customized phage therapies, today announced the acquisition of RondinX. The acquisition fortifies BiomX’s bacterial target discovery capabilities and supports its product development pipeline. In…
